Cocaine Use Disorder: Mechanisms, Health Effects, and Treatment

Introduction

Cocaine use disorder affects approximately 1.4 million Americans and is associated with significant medical, psychiatric, and social consequences. While cocaine use peaked in the 1980s, it has resurged in recent years — particularly in combination with fentanyl, which is increasingly found in the cocaine supply and has dramatically increased cocaine-related overdose deaths. Understanding cocaine use disorder — its mechanisms, consequences, and treatment — is essential for effective prevention and treatment.

Key Definitions

Cocaine: A powerful stimulant derived from the coca plant. Available as powder cocaine (snorted or injected) and crack cocaine (smoked). Both forms are highly addictive.

Crack cocaine: A freebase form of cocaine that is smoked, producing a rapid, intense high of short duration. The rapid onset and short duration of crack cocaine make it particularly addictive.

Dopamine transporter (DAT): The protein that removes dopamine from the synapse. Cocaine blocks DAT, causing dopamine to accumulate and producing euphoria.

Speedball: A combination of cocaine and heroin (or other opioids). Particularly dangerous due to the combined cardiovascular and respiratory effects.

Cocaine-induced cardiovascular events: Heart attacks, strokes, and arrhythmias caused by cocaine's effects on the cardiovascular system. Can occur even in young, healthy people with no prior cardiovascular disease.

Scientific Background: How Cocaine Affects the Brain

Cocaine produces its effects primarily by blocking the reuptake transporters for dopamine, norepinephrine, and serotonin — preventing these neurotransmitters from being removed from the synapse and causing them to accumulate. The dopamine accumulation in the nucleus accumbens produces cocaine's characteristic euphoria.

Unlike methamphetamine, cocaine does not cause direct neurotoxicity to dopamine neurons. However, it produces significant neuroadaptation with chronic use:

Dopamine system downregulation: Chronic cocaine use reduces D2 receptor density and dopamine release in the striatum, producing tolerance and the anhedonia of cocaine withdrawal.

DeltaFosB accumulation: Cocaine produces one of the most dramatic accumulations of DeltaFosB — the transcription factor that serves as a "molecular switch" for addiction — of any substance. DeltaFosB accumulation in the nucleus accumbens alters the expression of hundreds of genes involved in reward, plasticity, and stress, contributing to the lasting changes in reward processing that characterize cocaine addiction.

Glutamate dysregulation: Chronic cocaine use dysregulates glutamate homeostasis in the nucleus accumbens, contributing to craving and relapse. Restoration of glutamate homeostasis — through N-acetylcysteine (NAC) or other interventions — may reduce cocaine craving.

Prefrontal cortex changes: Cocaine produces significant changes in prefrontal cortex structure and function, reducing gray matter volume and impairing executive function. These changes contribute to the impaired decision-making and loss of control characteristic of cocaine addiction.

Health Consequences

Cardiovascular: Cocaine is the most common cause of drug-related emergency department visits in the United States. It produces intense vasoconstriction, increased heart rate and blood pressure, and coronary artery spasm, dramatically increasing the risk of heart attack and stroke. These cardiovascular effects can occur even in young, healthy people with no prior cardiovascular disease and at any dose. Cocaine-associated chest pain is a medical emergency.

Neurological: Cocaine increases the risk of stroke through multiple mechanisms — vasoconstriction, hypertension, and increased platelet aggregation. It can also cause seizures, particularly at high doses or with crack cocaine. Chronic cocaine use produces cognitive impairment, particularly in attention, working memory, and executive function.

Psychiatric: Cocaine use is associated with paranoia, anxiety, and psychosis during intoxication, and with depression, anxiety, and suicidal ideation during withdrawal. Cocaine-induced psychosis can be severe and may persist for days to weeks after cessation.

Nasal damage: Chronic intranasal cocaine use damages the nasal septum and mucous membranes, potentially causing septal perforation and loss of smell.

Pulmonary: Crack cocaine smoking can cause "crack lung" — a syndrome of acute respiratory distress, hemoptysis, and pulmonary infiltrates — and is associated with chronic pulmonary disease.

Cocaine Withdrawal

Cocaine withdrawal is not medically dangerous but produces significant psychological symptoms:

Acute withdrawal ("crash"): Immediately following a cocaine binge, users experience a "crash" characterized by extreme fatigue, depression, increased appetite, and intense craving. This crash reflects the depletion of dopamine stores produced by cocaine use.

Subacute withdrawal (days 1-10): Continued depression, anhedonia, fatigue, and craving. Sleep disturbances are common.

Protracted withdrawal (weeks to months): Episodic craving, particularly in response to drug-related cues. The cue-induced craving of cocaine withdrawal can be intense and persistent, driven by the powerful conditioned memories formed during cocaine use.

Treatment

Like methamphetamine use disorder, there are currently no FDA-approved medications for cocaine use disorder. Treatment relies primarily on behavioral therapies:

Contingency Management (CM): CM is the most evidence-based treatment for cocaine use disorder. Multiple randomized controlled trials have shown that CM significantly reduces cocaine use and improves treatment retention. The use of escalating vouchers — where the value of rewards increases with consecutive negative urine tests — is particularly effective.

Cognitive Behavioral Therapy (CBT): CBT for cocaine use disorder focuses on identifying and managing triggers, developing coping skills, and building a recovery-supportive lifestyle. Research has shown that CBT effects persist after treatment ends, suggesting that it produces lasting changes in cognitive and behavioral patterns.

Emerging medications:

• N-acetylcysteine (NAC): NAC restores glutamate homeostasis in the nucleus accumbens and has shown promise in reducing cocaine craving in clinical trials.
• Modafinil: A wakefulness-promoting agent that has shown some efficacy in reducing cocaine use in clinical trials, possibly by improving prefrontal cortex function.
• Disulfiram: Has shown some efficacy in reducing cocaine use in clinical trials, possibly through its effects on dopamine metabolism.
• Cocaine vaccine: A vaccine that stimulates the immune system to produce antibodies that bind cocaine and prevent it from crossing the blood-brain barrier is in clinical development. Early results are promising but not yet sufficient for FDA approval.

Frequently Asked Questions

Is crack cocaine more addictive than powder cocaine?
Yes. The rapid onset and short duration of crack cocaine's effects — produced by smoking — make it more addictive than powder cocaine. The faster a drug reaches the brain, the more reinforcing it is. Crack cocaine produces a peak effect within seconds of smoking, compared to minutes for intranasal powder cocaine.

Can cocaine cause a heart attack in young people?
Yes. Cocaine is a leading cause of heart attacks in people under 45. It can cause heart attack through multiple mechanisms — coronary artery spasm, thrombosis, and direct myocardial toxicity — even in people with no prior cardiovascular disease and at any dose.

Why is cocaine mixed with fentanyl?
Illicit drug suppliers add fentanyl to cocaine to increase potency and reduce costs. This practice is extremely dangerous because cocaine users may not be aware of the fentanyl content and may not have opioid tolerance, making them highly vulnerable to overdose. Fentanyl test strips can detect fentanyl in cocaine and other drugs.

Key Takeaways

• Cocaine produces euphoria by blocking dopamine reuptake, causing dopamine to accumulate in the nucleus accumbens.
• Cocaine is the most common cause of drug-related emergency department visits and can cause heart attack and stroke even in young, healthy people.
• Contingency management is the most evidence-based treatment for cocaine use disorder.
• The increasing presence of fentanyl in the cocaine supply has dramatically increased cocaine-related overdose deaths.
• Several promising medications are in development for cocaine use disorder, including NAC and a cocaine vaccine.

Additional Resources

Related articles on Sobriety Navigator: Dopamine and Reward Pathways, Epigenetics and Addiction, Contingency Management, Cognitive Recovery Timeline.